Literature DB >> 23564454

Minimal interleukin 6 (IL-6) receptor stalk composition for IL-6 receptor shedding and IL-6 classic signaling.

Paul Baran1, Rebecca Nitz, Joachim Grötzinger, Jürgen Scheller, Christoph Garbers.   

Abstract

Signaling of the pleiotropic cytokine Interleukin-6 (IL-6) is coordinated by membrane-bound and soluble forms of the IL-6 receptor (IL-6R) in processes called classic and trans-signaling, respectively. The soluble IL-6R is mainly generated by ADAM10- and ADAM17-mediated ectodomain shedding. Little is known about the role of the 52-amino acid-residue-long IL-6R stalk region in shedding and signal transduction. Therefore, we generated and analyzed IL-6R stalk region deletion variants for cleavability and biological activity. Deletion of 10 amino acids of the stalk region surrounding the ADAM17 cleavage site substantially blocked IL-6R proteolysis by ADAM17 but only slightly affected proteolysis by ADAM10. Interestingly, additional deletion of the remaining five juxtamembrane-located amino acids also abrogated ADAM10-mediated IL-6R shedding. Larger deletions within the stalk region, that do not necessarily include the ADAM17 cleavage site, also reduced ADAM10 and ADAM17-mediated IL-6R shedding, questioning the importance of cleavage site recognition. Furthermore, we show that a 22-amino acid-long stalk region is minimally required for IL-6 classic signaling. The gp130 cytokine binding sites are separated from the plasma membrane by ~96 Å. 22 amino acid residues, however, span maximally 83.6 Å (3.8 Å/amino acid), indicating that the three juxtamembrane fibronectin domains of gp130 are not necessarily elongated but somehow flexed to allow IL-6 classic signaling. Our findings underline a dual role of the IL-6R stalk region in IL-6 signaling. In IL-6 trans-signaling, it regulates proper proteolysis by ADAM10 and ADAM17. In IL-6 classic-signaling, it acts as a spacer to ensure IL-6·IL-6R·gp130 signal complex formation.

Entities:  

Keywords:  ADAM ADAMTS; ADAM10; ADAM17; IL-6 Signal Transduction; Interleukin; Interleukin-6; Interleukin-6 Receptor; Proteolytic Enzymes; Receptor Structure-Function; Signal Transduction

Mesh:

Substances:

Year:  2013        PMID: 23564454      PMCID: PMC3663500          DOI: 10.1074/jbc.M113.466169

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

1.  Complex of soluble human IL-6-receptor/IL-6 up-regulates expression of acute-phase proteins.

Authors:  A Mackiewicz; H Schooltink; P C Heinrich; S Rose-John
Journal:  J Immunol       Date:  1992-09-15       Impact factor: 5.422

2.  Leukocyte migration is regulated by L-selectin endoproteolytic release.

Authors:  Guglielmo M Venturi; LiLi Tu; Takafumi Kadono; Adil I Khan; Yoko Fujimoto; Philip Oshel; Cheryl B Bock; Ann S Miller; Ralph M Albrecht; Paul Kubes; Douglas A Steeber; Thomas F Tedder
Journal:  Immunity       Date:  2003-11       Impact factor: 31.745

3.  Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor.

Authors:  J A Lust; K A Donovan; M P Kline; P R Greipp; R A Kyle; N J Maihle
Journal:  Cytokine       Date:  1992-03       Impact factor: 3.861

4.  Shedding of interleukin-6 receptor and tumor necrosis factor alpha. Contribution of the stalk sequence to the cleavage pattern of transmembrane proteins.

Authors:  K Althoff; P Reddy; N Voltz; S Rose-John; J Müllberg
Journal:  Eur J Biochem       Date:  2000-05

5.  Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses.

Authors:  T Jostock; J Müllberg; S Ozbek; R Atreya; G Blinn; N Voltz; M Fischer; M F Neurath; S Rose-John
Journal:  Eur J Biochem       Date:  2001-01

6.  Enhanced transgene expression in primitive hematopoietic progenitor cells and embryonic stem cells efficiently transduced by optimized retroviral hybrid vectors.

Authors:  R Ketteler; S Glaser; O Sandra; U M Martens; U Klingmüller
Journal:  Gene Ther       Date:  2002-04       Impact factor: 5.250

7.  The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion.

Authors:  Christian Hundhausen; Dominika Misztela; Theo A Berkhout; Neil Broadway; Paul Saftig; Karina Reiss; Dieter Hartmann; Falk Fahrenholz; Rolf Postina; Vance Matthews; Karl-Josef Kallen; Stefan Rose-John; Andreas Ludwig
Journal:  Blood       Date:  2003-04-24       Impact factor: 22.113

8.  The disintegrin/metalloprotease ADAM 10 is essential for Notch signalling but not for alpha-secretase activity in fibroblasts.

Authors:  Dieter Hartmann; Bart de Strooper; Lutgarde Serneels; Katleen Craessaerts; An Herreman; Wim Annaert; Lieve Umans; Torben Lübke; Anna Lena Illert; Kurt von Figura; Paul Saftig
Journal:  Hum Mol Genet       Date:  2002-10-01       Impact factor: 6.150

9.  Hexameric structure and assembly of the interleukin-6/IL-6 alpha-receptor/gp130 complex.

Authors:  Martin J Boulanger; Dar-chone Chow; Elena E Brevnova; K Christopher Garcia
Journal:  Science       Date:  2003-06-27       Impact factor: 47.728

10.  L-selectin shedding does not regulate constitutive T cell trafficking but controls the migration pathways of antigen-activated T lymphocytes.

Authors:  Elena Galkina; Kyriakos Tanousis; Graham Preece; Mauro Tolaini; Dimitris Kioussis; Oliver Florey; Dorian O Haskard; Thomas F Tedder; Ann Ager
Journal:  J Exp Med       Date:  2003-11-03       Impact factor: 14.307

View more
  26 in total

1.  Synthetic Deletion of the Interleukin 23 Receptor (IL-23R) Stalk Region Led to Autonomous IL-23R Homodimerization and Activation.

Authors:  Thorben M Hummel; Theresa Ackfeld; Marco Schönberg; Gregor Ciupka; Falk Schulz; Anne Oberdoerster; Joachim Grötzinger; Jürgen Scheller; Doreen M Floss
Journal:  Mol Cell Biol       Date:  2017-08-11       Impact factor: 4.272

Review 2.  Targeting the IL-6/JAK/STAT3 signalling axis in cancer.

Authors:  Daniel E Johnson; Rachel A O'Keefe; Jennifer R Grandis
Journal:  Nat Rev Clin Oncol       Date:  2018-02-06       Impact factor: 66.675

3.  A disintegrin and metalloprotease (ADAM) 10 and ADAM17 are major sheddases of T cell immunoglobulin and mucin domain 3 (Tim-3).

Authors:  Katja Möller-Hackbarth; Christin Dewitz; Olga Schweigert; Ahmad Trad; Christoph Garbers; Stefan Rose-John; Jürgen Scheller
Journal:  J Biol Chem       Date:  2013-10-11       Impact factor: 5.157

4.  A Common Variant of IL-6R is Associated with Elevated IL-6 Pathway Activity in Alzheimer's Disease Brains.

Authors:  Patrick C G Haddick; Jessica L Larson; Nisha Rathore; Tushar R Bhangale; Qui T Phung; Karpagam Srinivasan; David V Hansen; Jennie R Lill; Margaret A Pericak-Vance; Jonathan Haines; Lindsay A Farrer; John S Kauwe; Gerard D Schellenberg; Carlos Cruchaga; Alison M Goate; Timothy W Behrens; Ryan J Watts; Robert R Graham; Joshua S Kaminker; Marcel van der Brug
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

5.  Roles for trafficking and O-linked glycosylation in the turnover of model cell surface proteins.

Authors:  Darya Karabasheva; Nelson B Cole; Julie G Donaldson
Journal:  J Biol Chem       Date:  2014-06-02       Impact factor: 5.157

Review 6.  IL-6 as a keystone cytokine in health and disease.

Authors:  Christopher A Hunter; Simon A Jones
Journal:  Nat Immunol       Date:  2015-05       Impact factor: 25.606

7.  The length of the interleukin-11 receptor stalk determines its capacity for classic signaling.

Authors:  Juliane Lokau; Christoph Garbers
Journal:  J Biol Chem       Date:  2018-03-09       Impact factor: 5.157

8.  A disintegrin and metalloprotease 17 dynamic interaction sequence, the sweet tooth for the human interleukin 6 receptor.

Authors:  Stefan Düsterhöft; Katharina Höbel; Mirja Oldefest; Juliane Lokau; Georg H Waetzig; Athena Chalaris; Christoph Garbers; Jürgen Scheller; Stefan Rose-John; Inken Lorenzen; Joachim Grötzinger
Journal:  J Biol Chem       Date:  2014-04-30       Impact factor: 5.157

9.  RAID3--An interleukin-6 receptor-binding aptamer with post-selective modification-resistant affinity.

Authors:  Florian Mittelberger; Cindy Meyer; Georg H Waetzig; Martin Zacharias; Erica Valentini; Dmitri I Svergun; Katharina Berg; Inken Lorenzen; Joachim Grötzinger; Stefan Rose-John; Ulrich Hahn
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

10.  Different Soluble Forms of the Interleukin-6 Family Signal Transducer gp130 Fine-tune the Blockade of Interleukin-6 Trans-signaling.

Authors:  Janina Wolf; Georg H Waetzig; Athena Chalaris; Torsten M Reinheimer; Henning Wege; Stefan Rose-John; Christoph Garbers
Journal:  J Biol Chem       Date:  2016-05-23       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.